DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Syncom Formulations (India) Limited — Board Meeting Intimation

NSE 5 hrs ago·6 Aug 2026, 12:12 pm

Company NSE

Syncom Formulations (India) Limited has announced that its board will meet on August 11, 2026, to review and approve its unaudited financial results for the quarter ending June 2026. The agenda also includes considering any dividend declaration or other significant business matters. This meeting is a standard procedural step for the company to finalize its financial reporting for the period.

For investors, this announcement is a key trigger to watch. The release of quarterly results will provide a fresh look at the company's operational performance, profitability, and cash flow. Additionally, any decision on dividend distribution will be of particular interest to income-focused investors. The market will closely monitor the figures to gauge the company's growth trajectory and future outlook.